2023 Form 5500 filing — Mallinckrodt Pharmaceuticals Retirement Savings And Investment Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015094904NAL0029175265001) for Mallinckrodt Pharmaceuticals Retirement Savings And Investment Plan, reported by Meh, Inc. under EIN 65-0952696 and plan number 001. It reports 4,305 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241015094904NAL0029175265001
Filing year
2023
Form type
2
Plan sponsor
Meh, Inc.
EIN
65-0952696
Plan number
001
Location
Hazelwood, MO
Participants
4,305
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$778,922,957
Total liabilities (EOY)
$0
Net assets (EOY)
$778,922,957
Employer contributions
$19,084,021
Participant contributions
$29,886,563
Total income / additions
$184,820,027
Benefits paid
$90,475,923
Administrative expenses
$218,048
Total expenses
$90,693,806
Net increase / (decrease)
$94,126,221
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$133,048$0
Capfinancial Partners LLCCONSULTANT$85,000not reported in the loaded dataset

Related Form 5500 pages